Delivery Order SPE2DB24D2100-SPE2DB25FBFSM
- Not listed
- The Defense Logistics Agency awarded a $4,628.72 delivery order to AmerisourceBergen Drug Corp for VYEPTI (eptinezumab) 100 mg/ml vials, with performance at the contractor's Conshohocken, Pennsylvania location and an ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $20,829.24 to AmerisourceBergen Drug Corp for the supply of VYEPTI 100 MG/ML Vial on August 4, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for VYEPTI 100 mg/ml vials valued at $1,157.18 under a firm fixed price contract. The award, issued on August 7, 2025, with an ultimate completion date of August 28, 2025, represents a competitively awarded, non-set-aside procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,628.72 to AmerisourceBergen Drug Corp for VYEPTI 100 mg/ml vials, with an ultimate completion date of August 18, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded through an open procurement process. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $4,628.72 firm fixed price delivery order to AmerisourceBergen Drug Corp for VYEPTI 100 mg/mL vials, with an ultimate completion date of August 8, 2025. This non-set-aside contract was competitively awarded on July 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,471.54 for VYEPTI 100 mg/ml vials, with an ultimate completion date of August 12, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is listed as...
- The Defense Logistics Agency awarded a $4,628.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Vyepti 100 mg/ml vials. This non-set-aside contract is scheduled for completion by August 12, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- This is a $57,859.00 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VYEPTI 100 MG/ML VIALML, a pharmaceutical product. The contract has an ultimate completion date of August 5, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This contract award, valued at $5,785.90, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of VYEPTI 100 MG/ML vials, a prescription medication, with a completion date of January 28, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $46,287.20 firm fixed-price contract is for the supply of VYEPTI 100 MG/ML VIALML, a medication, with a performance period ending on February 21, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB25FBFSMDelivery Order
The Defense Logistics Agency (DLA) awarded a $57,859.00 delivery order to AmerisourceBergen Drug Corp for VYEPTI 100 MG/ML Vial on August 7, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price contract, awarded without set-aside designation, represents a competitively awarded delivery order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical supply will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order falls within AmerisourceBergen's role as a major pharmaceutical distributor supporting federal medical procurement for military and veteran healthcare systems. VYEPTI (eptinezumab), a migraine treatment, represents the type of specialty medication encompassed within the company's comprehensive global pharmaceutical support vehicle with DLA. As a critical vendor within the federal medical supply chain, AmerisourceBergen maintains an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard through DLA's flexible contract framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $57.9k | 8/7/25 |